We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

#How Has The Tumor Profiling Market Size Shifted, And What Is the Outlook Through 2034?#_x000D_

In recent years, the expansion of the tumor profiling market has been swift. A growth from $10.16 billion in 2024 to $11.21 billion in 2025 is expected, indicating a compound annual growth rate (CAGR) of 10.3%. This rise in the past period is due to factors such as the growing number of cancer cases, the escalating demand for personalized medication, increased healthcare spending, the rising acceptance of companion diagnostics, and heightened consciousness about early cancer detection._x000D_

_x000D_

In the next few years, the tumor profiling market is projected to experience significant expansion, reaching $16.48 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 10.1%. The predicted upsurge during the forecast period can be linked to the escalating adoption of liquid biopsy methodologies, heightened investment in cancer-related R&D, an increasing aged population, expanded use of targeted therapies, and a rising number of collaborations in cancer research. Forecast trends include a shift towards companion diagnostics, a surge in multi-gene testing, advanced developments in next-generation sequencing, the incorporation of Artificial Intelligence (AI) in cancer diagnostics, and progress in tumor profiling technologies._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24420&type=smp_x000D_

_x000D_

#What are the Fundamental Drivers and Innovations Shaping the Tumor Profiling Market?#_x000D_

The burgeoning interest in customized therapy is anticipated to fuel the expansion of the tumor profiling market in the future. Customized therapy involves a method that adapts health care treatments to every patient’s unique traits. This surge is propelled by individuals who prefer more accurate therapies that yield better results and fewer adverse reactions in contrast to conventional therapies. Tumor profiling is facilitating customized therapy by revealing particular genetic alterations and biomarkers in a patient’s tumor, helping in the administration of targeted treatments and minimizing side effects. An instance would be in February 2024, as a report revealed by the Personalized Medicine Coalition, a United States establishment devoted to promoting customized medicine, showed that customized medicines made up for over one-third of all fresh drug approvals in 2023, symbolizing the fourth uninterrupted year of this pattern. Therefore, the increasing demand for customized medicine is leading to growth in the tumor profiling market._x000D_

_x000D_

#How Is the Tumor Profiling Market Segmented?#_x000D_

The tumor profiling market covered in this report is segmented –_x000D_

_x000D_

1) By Technique: Genomics, Proteomics, Epigenetics, Metabolomics_x000D_

2) By Technology: Sequencing Techniques, Quantitative Polymerase Chain Reaction (qPCR), Immunohistochemistry, In Situ Hybridization (ISH), Microarray_x000D_

3) By Application: Personalized Cancer Medicine, Oncological Diagnostics, Research_x000D_

_x000D_

Subsegments:_x000D_

1) By Genomics: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarrays, Sanger sequencing_x000D_

2) By Proteomics: Mass Spectrometry (MS), Protein Microarrays, Immunohistochemistry (IHC), Western Blotting_x000D_

3) By Epigenetics: DNA Methylation Analysis, Chromatin Immunoprecipitation Sequencing (ChIP-seq), Histone Modification Profiling, Non-Coding RNA Analysis_x000D_

4) By Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy, Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), Capillary Electrophoresis-Mass Spectrometry (CE-MS)_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24420&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Tumor Profiling Market Growth?#_x000D_

North America was the largest region in the tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Key Trends Are Shaping the Future of the Tumor Profiling Market?#_x000D_

Leading firms in the tumor profiling industry are concentrating their efforts on the development of cutting-edge solutions, such as diagnostic applications powered by artificial intelligence (AI), to improve both precision and effectiveness in cancer treatment. AI implies employing superior computational techniques to examine intricate genomic, proteomic, and clinical statistics, which facilitates speedier diagnostics, tailored treatment plans, and superior disease progression surveillance. For example, in January 2025, Panakeia Technologies LTD, a UK-based enterprise focused on AI-enabled software for cancer diagnosis and treatment, introduced PANProfiler Colon. This is a specially built AI-supported software solution to profile crucial molecular biomarkers such as microsatellite instability (MSI) and mismatch repair deficiency (dMMR)—derived from H and E-stained images of colon cancer tissue specimens. This digital resource facilitates expedient and precise molecular profiling of tumors, which is crucial for the diagnosis of colorectal cancer, detecting instances of Lynch syndrome, and guiding personalized treatment choices._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/tumor-profiling-global-market-report_x000D_

_x000D_

#How Is the Tumor Profiling Market Defined and What Are Its Core Parameters?#_x000D_

Tumor profiling refers to a set of techniques used to analyze and characterize the genetic and molecular features of a tumor, which helps to identify specific mutations, gene expression patterns, and other molecular characteristics of cancer cells, and this tumor profiling can provide crucial information about the biology of a particular tumor, guide treatment decisions, and inform personalized therapies._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=24420&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model